Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on the Safety and Effectiveness of mRNA-3927 for Patients with Propionic Acidemia
The NetherlandsStudy on the Effectiveness of Enlicitide Chloride in Reducing Cardiovascular Events in Patients with Atherosclerotic Cardiovascular Disease
The NetherlandsStudy of BMS-986012, carboplatin, etoposide and nivolumab combination as first treatment for patients with extensive-stage small cell lung cancer
The NetherlandsStudy on the Safety of DNL310 for Children with Hunter Syndrome
The NetherlandsStudy of Durvalumab with Radiation Therapy for Patients with Early Stage Non-Small Cell Lung Cancer and Osimertinib for Those with EGFR Mutation
The NetherlandsStudy comparing stem cell transplantation versus alemtuzumab, cladribine or ocrelizumab in patients with aggressive relapsing-remitting multiple sclerosis
The NetherlandsStudy of talazoparib and enzalutamide combination in men with DDR gene mutated metastatic castration-sensitive prostate cancer
The NetherlandsStudy Comparing bb2121 with Standard Treatments for Patients with Relapsed and Refractory Multiple Myeloma
The NetherlandsStudy on Leflunomide and Hydroxychloroquine for Patients with Primary Sjögren's Syndrome
The NetherlandsStudy of Immunotherapy Combinations with GSK4428859, Dostarlimab, and GSK6097608 for Patients with Advanced Non-Small Cell Lung Cancer
The NetherlandsStudy Comparing Crovalimab and Eculizumab for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently on Complement Inhibitors
The NetherlandsStudy of Disitamab Vedotin and Pembrolizumab for Patients with Untreated Advanced Urothelial Cancer Expressing HER2
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Studies compare various treatment options to improve patient outcomes and survival rates.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.
Trials examine innovative treatment strategies and personalized approaches.
Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.
Research aims to improve treatment outcomes while minimizing toxicity.
Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.
Focus on improving surgical outcomes and treatment effectiveness.
Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.
Research aims to improve detection and treatment of brain metastases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
